Precision Fermentation-Derived Biomaterials Market Report 2026

The precision fermentation-derived biomaterials market size has grown rapidly in recent years. It will grow from $1.72 billion in 2025 to $1.94 billion in 2026 at a compound annual growth rate (CAGR) of 13%. The growth in the historic period can be attributed to growing demand for sustainable biomaterials, advancements in synthetic biology research, increasing investments in industrial biotechnology, rising adoption of bio-based alternatives in food and healthcare, expansion of fermentation infrastructure capabilities.

The precision fermentation-derived biomaterials market size is expected to see rapid growth in the next few years. It will grow to $3.2 billion by 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to increasing commercialization of precision fermentation products, rising demand for alternative proteins and enzymes, growing integration of automated bioprocessing systems, expansion of bio-manufacturing partnerships and collaborations, increasing focus on low-carbon material production. Major trends in the forecast period include scalable bio-based material production, increasing adoption of microbial fermentation platforms, development of animal-free biomaterials, expansion of high-purity functional biomolecule manufacturing, growing commercialization of next-generation bioprocessing technologies.

The growing preference for animal-free products worldwide is expected to propel the growth of the precision fermentation-derived biomaterials market going forward. Animal-free products refer to plant-based, fermented, or cell-free alternatives developed without the use of animal-derived inputs. The growing preference for such products is driven by increasing consumer awareness of health, sustainability, and ethical considerations, along with improved availability of high-quality alternatives. Precision fermentation-derived biomaterials play a significant role in this shift by providing scalable and sustainable ingredients that replicate the functionality of animal-derived components, facilitating the production of plant-based dairy, meat, and related products. For instance, in January 2025, according to Veganuary, approximately 25.8 million people worldwide participated in the Veganuary campaign, reflecting increasing adoption of vegan lifestyles. Therefore, the growing preference for animal-free products is driving the growth of the precision fermentation-derived biomaterials market.

Leading companies operating in the precision fermentation-derived biomaterials market are concentrating on developing innovative solutions, such as precision-fermented functional dairy proteins, to meet the rising demand for animal-free, sustainable, and high-performance biomaterials. Precision fermentation utilizes engineered microorganisms to produce specific proteins and biomolecules without relying on animal sources, offering advantages such as reduced environmental impact, consistent quality, and scalable production compared to conventional methods. For instance, in March 2025, Vivici launched Vivitein BLG, an animal-free beta-lactoglobulin (BLG) dairy protein, in the U. S. market. Produced through microbial fermentation, the ingredient delivers functional and nutritional properties comparable to traditional whey proteins and is suited for applications such as protein beverages, powders, and vegan-friendly nutrition products. Additionally, the product offers lower water usage and reduced carbon footprint compared to conventional dairy protein production, highlighting the role of precision fermentation in advancing sustainable and high-performance biomaterials.

In May 2025, Amyris, Inc. acquired full ownership of the RealSweet precision fermentation plant for an undisclosed amount. Through this acquisition, Amyris aims to strengthen its production capabilities for fermented ingredients using precision fermentation technology. The RealSweet precision fermentation plant is a Brazil-based facility that produces specialty biomaterials through industrial-scale precision fermentation, enabling scalable and sustainable production of high-quality ingredients.

Major companies operating in the precision fermentation-derived biomaterials market are Evonik Industries AG, Novozymes A/S, Perfect Day Inc., Impossible Foods Inc., Standing Ovation SAS, The EVERY Company Inc., Formo Bio GmbH, Melt & Marble AB, TurtleTree Labs Pte. Ltd., Imagindairy Ltd., Eden Brew Pty Ltd., Onego Bio Ltd., Planet A Foods GmbH, Remilk Ltd., Verley GmbH, Vivici B. V., Change Foods Inc., De Novo Foodlabs Inc., Protera Bio SAS, Helaina Inc., Zero Cow Factory Pvt. Ltd., MeliBio Inc., Motif FoodWorks Inc., Shiru Inc., C16 Biosciences Inc., New Culture Inc., Better Dairy Ltd.

North America was the largest region in the precision fermentation-derived biomaterials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision fermentation-derived biomaterials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the precision fermentation-derived biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The precision fermentation-derived biomaterials market consists of revenues earned by entities by providing services such as strain engineering services, fermentation process development services, bioprocess optimization services, downstream processing services, and contract manufacturing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The precision fermentation-derived biomaterials market also includes sales of bioreactors, fermentation tanks, microbial strains, growth media, enzymes, proteins, bio-based polymers, purification systems, filtration equipment, and process control systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.